Stay updated with breaking news from Representing Growth. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
WAKIX® Net Revenue of $168.4 Million for Fourth Quarter and $582.0 Million for Full Year 2023; Representing Growth of ~31% and ~33%, Respectively U.S. Food and Drug Administration Granted...
/PRNewswire/ -- Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY) today reported preliminary, unaudited fourth quarter and full year 2023 net product revenue...
Gross Profit of $30.6 Million, Representing an Improvement of $3.9 Million YoY, Gross Profit Margin of 46.0% Net Loss of $14.0 Million, Compared to Net Income of $12.1 Million in Q2 2022 and Net Loss... -August 11, 2023 at 07:01 am- MarketScreener
08.05.2023 - 12-month Top-Line Data from the U.S.-based Phase 1 Clinical Trial of OTX-TKI (axitinib intravitreal implant) for the Treatment of Wet AMD to be Presented in June at the Clinical Trials at the Summit 2023 Meeting Presented Pre-Clinical and Clinical ...